Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-label Phase Ib Study of Preoperative Treatment With the KLK Inhibitor MDPK67b in Patients With Untreated Prostate Cancer

NCT05580107 is registered in ClinicalTrials.gov with Med Discovery SA as lead sponsor.

NCT NCT05580107
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05580107 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-label Phase Ib Study of Preoperative Treatment With the KLK Inhibitor MDPK67b in Patients With Untreated Prostate Cancer
Lead sponsor
Med Discovery SA
Phase
Phase 1
Overall status
Unknown status
Start date
August 9, 2021
Completion date
June 30, 2024
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer